A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria
Sponsor: Allena Pharmaceuticals
Listed as NCT03095885, this NA trial focuses on Hyperoxaluria and Kidney Stones and remains completed. Sponsored by Allena Pharmaceuticals, it has been updated 10 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Nov 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Sep 2021 — Nov 2021 [monthly]
Completed NA
-
Jan 2021 — Sep 2021 [monthly]
Completed NA
-
Apr 2020 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Apr 2020 [monthly]
Completed NA
-
May 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Allena Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .